NUBEQA cpr pell 300 mg 112 pce
7680675210015
CH-67521
L02BB06
07.16.2.
Reimbursement limitations:
NUBEQA.01
Après garantie de prise en charge des frais par l’assureur-maladie et consultation préalable du médecin-conseil.
…
1 / 3
google
Details
- Product number
- 6752101
- CPT
- -
- Packaging group
- 112
- Unit
- Tablette(n)
- Composition
- darolutamidum 300 mg, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium 2.7 mg, lactosum monohydricum, magnesii stearas, povidonum K 30, Überzug: hypromellosum, lactosum monohydricum, macrogolum 3350, E 171, pro compresso obducto corresp. lactosum monohydricum 186 mg.
Articles (1)
NUBEQA 300 mg, Filmtabletten
Filmtabletten
112
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.7 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
186.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 3203.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2023
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 67521
- Drug name
- NUBEQA, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L02BB06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/06/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NUBEQA cpr pell 300 mg 112 pce
- Description (DE)
- NUBEQA Filmtabl 300 mg 112 Stk
- Market launch
- 19/06/2020
- Narcotic (BTM)
- No